Johan Lantto, PhDProject and Portfolio Director at Symphogen
Dr. Lantto is a Project & Portfolio Director at Symphogen, a Servier company based in Denmark. Dr. Lantto holds a Ph.D. in Immunotechnology from Lund University, Sweden, where he studied antibody evolution and repertoire development. Dr. Lantto has more than 20 years of experience with antibody engineering and the development of therapeutic antibodies. For the past 17 years, Dr. Lantto has worked for Symphogen where he has been involved in the development of the company’s Symplex™ antibody discovery platform as well as been responsible for antibody drug discovery and development projects within infectious disease and oncology. Dr. Lantto has been responsible for six oncology projects that have been brought to the clinic by Symphogen.